NIH-funded research NIH-funded research

Gut microbiome biomarkers to tailor obesity-related colorectal cancer risk

Official title: Guild-Based Microbiome Biomarkers of Precision Risk Stratification for Obesity-related Cancer

Funded at University of Kansas Medical Center · NIH-11584617 · Data updated 2026-11-12

This grant aims to develop AI-powered microbiome clues from gut bacteria to better predict and stage colorectal cancer linked to obesity, helping people understand their risk and care options.

More Obesity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJune 3, 2026
Project endMarch 31, 2029
Funding year2026
Award (this year)$231,278
NIH project number5P20GM130423-08
Project IDNIH-11584617 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for or diagnosed with obesity-related colorectal cancer, including individuals from rural populations, who consent to microbiome analysis and AI-guided risk assessment.

Less likely to help

Individuals without colorectal cancer or obesity-related risk factors may not gain direct benefit, though broader knowledge could still inform future research.

What this research studies

Colorectal cancer linked to obesity is a major health concern, especially in rural communities. This research uses gut bacteria data and advanced AI to create an accurate classifier that can distinguish colorectal cancer from non-cancer and identify cancer stage. By focusing on genome-resolved microbial signals and interpretable AI, the project seeks to provide clearer risk stratification and disease insights that could guide personalized screening and treatment planning. The work builds on a validated framework of microbial guilds to translate microbiome science into practical, patient-relevant information.

Why it matters

Potential benefit: If successful, patients could benefit from earlier detection and more precise staging, leading to tailored prevention and treatment strategies.

How similar studies have gone: Prior work has shown that microbiome-based classifiers can differentiate cancer states and stages, supporting the potential for this approach with further refinement.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Zhao, Naisi — University of Kansas Medical Center
  • Study coordinator: Zhao, Naisi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.